WO2003099229A3 - Functional protein expression for rapid cell-free phenotyping - Google Patents

Functional protein expression for rapid cell-free phenotyping Download PDF

Info

Publication number
WO2003099229A3
WO2003099229A3 PCT/US2003/016681 US0316681W WO03099229A3 WO 2003099229 A3 WO2003099229 A3 WO 2003099229A3 US 0316681 W US0316681 W US 0316681W WO 03099229 A3 WO03099229 A3 WO 03099229A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenotyping
free
protein expression
functional protein
rapid cell
Prior art date
Application number
PCT/US2003/016681
Other languages
French (fr)
Other versions
WO2003099229A2 (en
Inventor
Laurence Mccarthy
Lilly Kong
Tang Shao
Xin Su
Original Assignee
Focus Technologies Inc
Laurence Mccarthy
Lilly Kong
Tang Shao
Xin Su
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Focus Technologies Inc, Laurence Mccarthy, Lilly Kong, Tang Shao, Xin Su filed Critical Focus Technologies Inc
Priority to AU2003243321A priority Critical patent/AU2003243321A1/en
Publication of WO2003099229A2 publication Critical patent/WO2003099229A2/en
Publication of WO2003099229A3 publication Critical patent/WO2003099229A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed herein are methods for assaying the phenotype of a bioactive molecule in the presence and absence of compounds that are known inhibitors of the phenotypable activity of the bioactive molecule. Also disclosed are methods for discovering compounds that can inhibit the phenotypable activity of a bioactive molecule. The methods and assays of the present invention are useful in developing and monitoring a chemotherapy regimen for a patient, to detect or prevent the emergence of a drug resistant phenotype.
PCT/US2003/016681 2002-05-28 2003-05-28 Functional protein expression for rapid cell-free phenotyping WO2003099229A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003243321A AU2003243321A1 (en) 2002-05-28 2003-05-28 Functional protein expression for rapid cell-free phenotyping

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38352702P 2002-05-28 2002-05-28
US38363102P 2002-05-28 2002-05-28
US60/383,631 2002-05-28
US60/383,527 2002-05-28

Publications (2)

Publication Number Publication Date
WO2003099229A2 WO2003099229A2 (en) 2003-12-04
WO2003099229A3 true WO2003099229A3 (en) 2004-10-28

Family

ID=29587009

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/016681 WO2003099229A2 (en) 2002-05-28 2003-05-28 Functional protein expression for rapid cell-free phenotyping

Country Status (2)

Country Link
AU (1) AU2003243321A1 (en)
WO (1) WO2003099229A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063562A (en) * 1994-09-16 2000-05-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst
US20010029022A1 (en) * 1999-08-25 2001-10-11 Christopher Fisher Methods of identifying anti-viral agents
US6537754B1 (en) * 1990-10-19 2003-03-25 Board Of Trustees Of The University Of Illinois Association of kinesin with sensitivity to chemotherapeutic drugs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537754B1 (en) * 1990-10-19 2003-03-25 Board Of Trustees Of The University Of Illinois Association of kinesin with sensitivity to chemotherapeutic drugs
US6063562A (en) * 1994-09-16 2000-05-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst
US20010029022A1 (en) * 1999-08-25 2001-10-11 Christopher Fisher Methods of identifying anti-viral agents

Also Published As

Publication number Publication date
WO2003099229A2 (en) 2003-12-04
AU2003243321A1 (en) 2003-12-12
AU2003243321A8 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
WO2008041953A3 (en) Dengue diagnosis and treatment
WO2006038208A3 (en) Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment
AU2003293015A1 (en) Microporous materials, methods, and articles for localizing and quantifying analytes
WO2007008276A3 (en) Turnover probes and use thereof for nucleic acid detection
DK1842113T3 (en) Durability indicator label after opening for food and the like
WO2008011170A3 (en) Methods for detecting the presence of expanded cgg repeats in the fmr1 gene 5' untranslated region
BRPI0516981A (en) mif inhibitors
WO2004057341A3 (en) Cvd assay
WO2008081094A3 (en) Method for the functional measurement of plasmatic thromboduline activity
WO2007065081A3 (en) Methods and systems for detecting concealed objects
AU2002243912A1 (en) Biosensor for detecting chemical agents
AU2003270093A1 (en) Method for determining endoglycosidase enzyme activity
NO20060065L (en) Tablets containing enrofloxacin and flavoring and / or flavoring agents
HK1061700A1 (en) An assay for detecting inhibitors of the enzyme myeloperokidase
WO2006044686A3 (en) Methods and compositions for predicting drug responses
EP1917532A4 (en) Monoclonal antibody against d-dimer and diagnosis agent for detecting d-dimer, crosslinked fibrin and its derivatives containing d-dimer by using the antibody
AU2003292842A1 (en) Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same
WO2003099229A3 (en) Functional protein expression for rapid cell-free phenotyping
WO2007010258A3 (en) Polymorphism in cysteine dioxygenase
AU2003243145A1 (en) Displacement assay for detection of small molecules
WO2004099240A3 (en) Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
AU2003263986A1 (en) Dynamically formed rotors for lock-in amplifier detection
WO2004043991A3 (en) Assay for tissue factor and factor viia
WO2005037859A3 (en) Fluorescence assay for kinase activity
WO2005014847A3 (en) Reagents, methods and kits for detecting feed enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP